# Peppermint-oil-nausea-meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/peppermint-oil-nausea-meta-analysis-evidence-review
Category: evidence-review
Summary: Peppermint-oil-nausea-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are gui
Last reviewed: 2026-08-07
Reviewed by: Migaku Evidence Review
# Peppermint-oil-nausea-meta-analysis: What the Evidence Says

## Quick Answer

Peppermint-oil-nausea-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 guideline, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition] | guideline | 2 | 2026-05-05 | 10.1155/grp/2610765 |
| Inhaling Peppermint Essential Oil as a Promising Complementary Therapy in the Treatment of Nausea and Vomiting | narrative review | 3 | 2025-07-17 | 10.3390/jcm14145069 |

## What The Sources Report

- Of the more than 70,000 people included in the survey, 40% showed clear evidence of FGID, according to the Rome IV criteria. [Storr M. (2026); evidence level 2]
- Nausea and vomiting (NV) are frequent symptoms that can occur in various conditions, including the postoperative period, as a result of chemotherapy treatment, or during pregnancy. [Gergő Dorottya (2025); evidence level 3]
- These symptoms result from continuous interactions among different parts of the gastrointestinal tract, including the enteric nervous system, the central nervous system, and the autonomic nervous system. [Gergő Dorottya (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For peppermint-oil-nausea-meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Storr M. (2026). S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]. DOI: 10.1155/grp/2610765. PMCID: PMC13140302. PMID: 42095009. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13140302/
- Gergő Dorottya (2025). Inhaling Peppermint Essential Oil as a Promising Complementary Therapy in the Treatment of Nausea and Vomiting. DOI: 10.3390/jcm14145069. PMCID: PMC12294836. PMID: 40725767. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12294836/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.